Riley G F, Feuer E J, Lubitz J D
Office of Research and Demonstrations, Health Care Financing Administration, Baltimore, MD 21244-1850, USA.
Med Care. 1996 Aug;34(8):826-36. doi: 10.1097/00005650-199608000-00009.
There is concern that financial incentives in health maintenance organizations (HMOs) might result in pressures to induce sicker members to disenroll. The authors compared disenrollment rates of Medicare HMO enrollees with cancer with disenrollment rates for cancer-free enrollees, using Medicare enrollment files linked to population-based tumor registry data from the Surveillance, Epidemiology, and End Results (SEER) Program.
The authors identified all aged Medicare beneficiaries who enrolled in an HMO located in a SEER reporting area during 1985 to 1989. Time to disenrollment was analyzed using a proportional hazards model.
Overall, cancer patients were no more likely to disenroll than others. However, persons diagnosed with cancer after enrollment were less likely to disenroll than other persons in Independent Practice Association (IPA) mode HMOs (relative risk [RR] = 0.79). Persons diagnosed with cancer after enrollment in group- and staff-model HMOs were about equally likely to disenroll as other persons (RR = 0.91). Persons diagnosed with cancer less than 18 months before enrollment were at high risk for disenrollment from both IPA and group-/staff-model HMOs (RR = 1.47 and 1.35). There was substantial variation among HMOs in overall disenrollment rates and in RRs for disenrollment by cancer patients.
The low disenrollment rates of patients diagnosed after enrollment do not support the contention that features intrinsic to managed care make HMOs unattractive to the seriously ill. Monitoring of selective disenrollment could be used as a screen for possible access and quality problems.
人们担心健康维护组织(HMO)中的经济激励措施可能会导致促使病情较重的成员退出保险的压力。作者使用与监测、流行病学和最终结果(SEER)计划中基于人群的肿瘤登记数据相链接的医疗保险参保档案,比较了患有癌症的医疗保险HMO参保者的退出率与无癌症参保者的退出率。
作者确定了1985年至1989年期间在SEER报告区域内加入HMO的所有老年医疗保险受益人。使用比例风险模型分析退出时间。
总体而言,癌症患者退出保险的可能性并不比其他人高。然而,参保后被诊断患有癌症的人比独立执业协会(IPA)模式的HMO中的其他人退出保险的可能性更小(相对风险[RR]=0.79)。在团体和员工模式的HMO中参保后被诊断患有癌症的人与其他人退出保险的可能性大致相同(RR=0.91)。参保前不到18个月被诊断患有癌症的人从IPA以及团体/员工模式的HMO退出保险的风险很高(RR=1.47和1.35)。不同HMO之间在总体退出率以及癌症患者退出保险的RR方面存在很大差异。
参保后被诊断出的患者较低的退出率并不支持如下观点,即管理式医疗的固有特征使HMO对重症患者缺乏吸引力。对选择性退出保险进行监测可作为筛查可能的就医机会和质量问题的一种手段。